Anxiolytic-like activity of oxytocin in male mice: Behavioral and autonomic evidence, therapeutic implications

Psychopharmacology

Volumn 185, Issue 2, 2006, Pages 218-225

  Ring, Robert H ^a   Malberg, Jessica E ^a   Potestio, Lisa ^a   Ping, Julia ^a   Boikess, Steve ^a   Luo, Bin ^a   Schechter, Lee E ^a   Rizzo, Stacey ^a   Rahman, Zia ^a   Rosenzweig Lipson, Sharon ^a  

^a PFIZER INC   (United States)

Author keywords

Anxiety; Anxiolytic; Autonomic; Benzodiazepine; Depression; Hyperthermia; Oxytocin; Stress; Vasopressin

Indexed keywords

1 [1 [4 (1 ACETYL 4 PIPERIDINYLOXY) 2 METHOXYBENZOYL] 4 PIPERIDINYL]BENZ[D][1,3]OXAZIN 2 ONE; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; OXYTOCIN; OXYTOCIN ANTAGONIST; OXYTOCIN RECEPTOR; UNCLASSIFIED DRUG; VASOPRESSIN; WAY 162720;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; CORE TEMPERATURE; DEPRESSION; DRUG EFFECT; HYPERTHERMIA; MALE; MAZE TEST; MOUSE; NEUROMODULATION; NEUROSECRETORY CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; STRESS; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; CHLORDIAZEPOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OXAZINES; OXYTOCIN; PIPERIDINES; RECEPTORS, OXYTOCIN;

EID: 33644848493     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0293-z     Document Type: Article

References (45)

1. Altemus M (1995) Neuropeptides in anxiety disorders. Effects of lactation. Ann N Y Acad Sci 771:697-707
2. Amico JA, Mantella RC, Vollmer RR, Li X (2004a) Anxiety and stress responses in female oxytocin deficient mice. J Neuroendocrinol 16:319-324
3. Amico JA, Vollmer RR, Karam JR, Lee PR, Li X, Koenig JI, McCarthy MM (2004b) Centrally administered oxytocin elicits exaggerated grooming in oxytocin null mice. Pharmacol Biochem Behav 78:333-339
4. Argiolas A, Gessa GL (1991) Central functions of oxytocin. Neurosci Biobehav Rev 15:217-231
5. Aron C, Simon P, Larousse C, Boissier JR (1971) Evaluation of a rapid technique for detecting minor tranquilizers. Neuropharmacology 10:459-469
6. Bale TL, Davis AM, Auger AP, Dorsa DM, McCarthy MM (2001) CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 21:2546-2552
7. Bielsky IF, Young LJ (2004) Oxytocin, vasopressin, and social recognition in mammals. Peptides 25:1565-1574
8. Borsini F, Lecci A, Volterra G, Meli A (1989) A model to measure anticipatory anxiety in mice? Psychopharmacology (Berl) 98:207-211
9. Bourin M, Hascoet M, Mansouri B, Colombel MC, Bradwejn J (1992) Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J Psychiatry Neurosci 17:72-77
10. DSM-IV-TR (2000) Diagnostic and statistical manual of mental disorders (DSM-IV-TR), 4th edn (text revision). American Psychiatric Association
11. Engelmann M, Ebner K, Wotjak CT, Landgraf R (1998) Endogenous oxytocin is involved in short-term olfactory memory in female rats. Behav Brain Res 90:89-94
12. 2-vasopressin and oxytocin by brain regions. Endocrinol Exp 19:29-37
13. Feifel D, Reza T (1999) Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology (Berl) 141:93-98
14. Hascoet M, Bourin M, Colombel MC, Fiocco AJ, Baker GB (2000) Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacol Biochem Behav 65:339-344
15. Holst S, Uvnas-Moberg K, Petersson M (2002) Postnatal oxytocin treatment and postnatal stroking of rats reduce blood pressure in adulthood. Auton Neurosci 99:85-90
16. Huber D, Veinante P, Stoop R (2005) Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308:245-248
17. Insel TR, Shapiro LE (1992) Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc Natl Acad Sci U S A 89:5981-5985
18. Jones PM, Robinson IC (1982) Differential clearance of neurophysin and neurohypophysial peptides from the cerebrospinal fluid in conscious guinea pigs. Neuroendocrinology 34:297-302
19. Kash SF, Tecott LH, Hodge C, Baekkeskov S (1999) Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 96:1698-1703
20. Kruse J (1986) Oxytocin: pharmacology and clinical application. J Fam Pract 23:473-479
21. Lee C, Rodgers RJ (1990) Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology (Berl) 102:507-513
22. Mantella RC, Vollmer RR, Li X, Amico JA (2003) Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 144:2291-2296
23. McCarthy MM (1990) Oxytocin inhibits infanticide in female house mice (Mus domesticus). Horm Behav 24:365-375
24. McCarthy MM, Kow LM, Pfaff DW (1992) Speculations concerning the physiological significance of central oxytocin in maternal behavior. Ann N Y Acad Sci 652:70-82
25. McCarthy MM, McDonald CH, Brooks PJ, Goldman D (1996) An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol Behav 60:1209-1215
26. Morris M, Callahan MF, Li P, Lucion AB (1995) Central oxytocin mediates stress-induced tachycardia. J Neuroendocrinol 7:455-459
27. Neumann ID (2002) Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog Brain Res 139:147-162
28. Neumann ID, Torner L, Wigger A (2000) Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 95:567-575
29. Numan M, Insel TR (2003) The neurobiology of parental behavior. Springer, Berlin Heidelberg New York
30. Oka T, Oka K, Hori T (2001) Mechanisms and mediators of psychological stress-induced rise in core temperature. Psychosom Med 63:476-486
31. Olivier B, Zethof T, Pattij T, van Boogaert M, van Oorschot R, Leahy C, Oosting R, Bouwknecht A, Veening J, van der Gugten J, Groenink L (2003) Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 463:117-132
32. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
33. Ring RH (2005) The central vasopressinergic and oxytocinergic systems as targets for psychiatric drug development neurohypophyseal hormones: from genomics and physiology to disease. American Physiological Society, Steamboat Springs, Colorado, p 162
34. Robinson DA, Wei F, Wang GD, Li P, Kim SJ, Vogt SK, Muglia LJ, Zhuo M (2002) Oxytocin mediates stress-induced analgesia in adult mice. J Physiol 540:593-606
35. Rodgers RJ, Lee C, Shepherd JK (1992) Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berl) 106:102-110
36. Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) 116:56-64
37. Tsatsaris V, Carbonne B, Cabrol D (2004) Atosiban for preterm labour. Drugs 64:375-382
38. Uvnäs-Moberg K, Widstrom A-M, Nissen E, Bjorvell H (1990) Personality traits in women 4 days postpartum and their correlation with plasma levels of oxytocin and prolactin. J Psychosom Obstet Gynaecol 11:261-273
39. Uvnäs-Moberg K, Alster P, Hillegaart V, Ahlenius S (1992) Oxytocin reduces exploratory motor behaviour and shifts the activity towards the centre of the arena in male rats. Acta Physiol Scand 145:429-430
40. Uvnäs-Moberg K, Ahlenius S, Hillegaart V, Alster P (1994) High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav 49:101-106
41. Williams PD, Clineschmidt BV, Erb JM, Freidinger RM, Guidotti MT, Lis EV, Pawluczyk JM, Pettibone DJ, Reiss DR, Veber DF et al (1995) 1-(1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl] piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist. J Med Chem 38:4634-4636
42. Windle RJ, Shanks N, Lightman SL, Ingram CD (1997) Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138:2829-2834
43. Windle RJ, Kershaw YM, Shanks N, Wood SA, Lightman SL, Ingram CD (2004) Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci 24:2974-2982
44. Winslow JT, Hearn EF, Ferguson J, Young LJ, Matzuk MM, Insel TR (2000) Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse. Horm Behav 37:145-155
45. Zethof TJ, Van der Heyden JA, Tolboom JT, Olivier B (1995) Stress-induced hyperthermia as a putative anxiety model. Eur J Pharmacol 294:125-135